Pine Labs (PINELABS)

FairStock Score: 49/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹164.86
Market Cap₹19,022.5 Cr
P/E Ratio149.87
ROCE-0.49%
ROE—%
Dividend Yield0%
Profit Growth264.4%
Debt/Equity0.07
Sales Growth19.6%
Free Cash Flow₹-436 Cr
Promoter Holding0%
52-Week Range₹134.75 — ₹284
SectorFinancial Technology (Fintech)
Book Value₹51.64

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a Buffett-style investor, I start with the numbers, not the story. Pine Labs trades at ₹164.86, market cap ₹19,023 Cr, P/E 149.87, P/B 3.19, and book value ₹51.64. Paying nearly 150 times earnings gives an earnings yield under 1%, so Mr. Market is already pricing in a lot of future success. The latest quarter shows sales ₹744 Cr and net profit ₹42 Cr, a thin ~5.6% net margin. Sales growth of 19.60% and five-year revenue CAGR 21.81% are respectable, and profit growth of 264.40% suggests operating leverage or a low base. But I need durable, cash-generating growth, not just accounting profit. Free cash flow is negative ₹436 Cr, and ROCE is -0.49%, meaning the business is not yet earning attractive returns on capital. Debt/equity is low at 0.07, which is a comfort, and Piotroski F-Score 6/9 is decent. However, ROE is unavailable, dividend yield is 0.00%, and promoter holding is 0.00%, so I see no owner-operator alignment or cash return. The 52-week range ₹134.75–₹284.00 shows volatility. FairStock Score 49/100—mixed—confirms this is not a clean Graham bargain. A fintech may have network effects, but the given figures do not prove a wide moat. At this valuation, the margin of safety is thin. If profits keep compounding and free cash flow turns positive, it could grow into the multiple. Until then, I’d watch from the sidelines. Fast growth is not the same as a safe investment.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer